Compare AVNT & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVNT | HTGC |
|---|---|---|
| Founded | 1927 | 2003 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Major Chemicals | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.8B |
| IPO Year | 2000 | N/A |
| Metric | AVNT | HTGC |
|---|---|---|
| Price | $40.22 | $14.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $41.50 | $19.25 |
| AVG Volume (30 Days) | 766.7K | ★ 4.0M |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | 2.75% | ★ 12.95% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $3,835,500,000.00 | N/A |
| Revenue This Year | $4.81 | $10.43 |
| Revenue Next Year | $3.37 | $3.88 |
| P/E Ratio | $45.12 | ★ $8.61 |
| Revenue Growth | ★ 1.71 | N/A |
| 52 Week Low | $27.48 | $13.77 |
| 52 Week High | $44.85 | $19.67 |
| Indicator | AVNT | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 53.34 | 36.33 |
| Support Level | $35.15 | N/A |
| Resistance Level | $44.85 | $19.38 |
| Average True Range (ATR) | 1.59 | 0.56 |
| MACD | -0.49 | -0.03 |
| Stochastic Oscillator | 22.46 | 37.08 |
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.